Terms under which SuperBio Labs supplies peptides at various stages of the regulatory process.
SuperBio Labs is a brand operated by SGI LLC, a company incorporated in Wyoming, USA, with commercial operations based in Quito, Ecuador. This notice establishes the terms under which SuperBio Labs supplies its products. By purchasing any product from the catalog, the buyer acknowledges and accepts the terms described below.
SuperBio Labs offers peptides in active clinical investigation, manufactured with HPLC ≥99% purity and an independent Certificate of Analysis (COA) per batch. Each compound is at a specific stage of the international regulatory process:
| Product | Regulatory status |
|---|---|
| Tirzepatide | FDA-approved (Mounjaro®/Zepbound®, 2022) — off-label use outside approved indication |
| Retatrutide | Phase 3 completed (TRIUMPH-4, Eli Lilly 2026) — pending regulatory approval |
| Semaglutide | FDA-approved (Ozempic®/Wegovy®) |
| PT-141 (Bremelanotide) | FDA-approved (Vyleesi®, 2019) for premenopausal HSDD |
| GHK-Cu | Approved for cosmetic use; extensive clinical research literature |
| Semax, Epithalon | Approved in the Russian medical formulary (40+ years of documented clinical use) |
| BPC-157, TB-500, MOTS-c | Preclinical and early-research phase; extensive scientific literature |
| Blends (GROW, WOLVERINE, GLOW, KLOW) | Combinations of the above compounds in informed-use proportions |
Products are intended for research protocols, use under qualified medical supervision, and exploratory clinical applications. Clinical application is at the discretion and responsibility of the treating physician or investigator.
By placing an order, the buyer declares and warrants that:
The information published at superbiolabs.com (including mechanism-of-action descriptions, suggested protocols, result timelines, reference doses, and combinations) is for informational and educational purposes only, based on published scientific literature and available clinical data.
This information does not constitute medical advice, recommendation of individual use, prescription, or therapeutic protocol. Any clinical decision must be made in consultation with a qualified medical professional familiar with the patient's specific context.
References to clinical trials (TRIUMPH, SURMOUNT, REDEFINE, STEP, SUSTAIN, among others) and published scientific literature are included for scientific context and evidence traceability.
SuperBio Labs guarantees the identity, HPLC ≥99% purity, and documented quality of each product delivered, verifiable through the corresponding batch COA. Beyond this product guarantee, SuperBio Labs assumes no responsibility for:
It is the buyer's exclusive responsibility to verify and comply with applicable regulations in their jurisdiction regarding importation, possession, handling, and disposal of the products. SuperBio Labs is not responsible for customs holds, seizures, fines, or regulatory consequences arising from buyer non-compliance with local laws.
SuperBio Labs reserves the right to update this disclaimer at any time. The current version is always the one published at superbiolabs.com/en/legal/disclaimer/.
By completing a purchase at superbiolabs.com, the buyer confirms having read, understood, and accepted this disclaimer in its entirety. Any inquiry may be directed to hello@superbiolabs.com.